FinanceAsianet Newsable
Wells Fargo initiates coverage on five biotech stocks
in5points
Wells Fargo initiated coverage on five biotech stocks.
Compass Pathways (CMPS) received an 'Equal-Weight' rating.
MDGL, DFTX, GHRS, and HELP received 'Overweight' ratings.
Wells Fargo thinks next-wave depression drugs could create new winners.
Story angle
Center-right
L
CL
C
CR
R
Mostly straight facts, with a light government- or market-friendly tilt.
About how the story is framed, not whether the facts are true.
Asianet Newsable
Center-right
Mixed factuality
Who owns this?
Asianet News Network
Rajeev Chandrasekhar / Jupiter Capital interests historically